TozinameranWorsening of immune thrombocytopenia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1948卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35966-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：409 / 409

相关论文

共 50 条

[1] TozinameranWorsening of vitiligo: case report
Reactions Weekly, 2022, 1913 (1) : 420 - 420
[2] ImmunostimulantsRecurrent immune thrombocytopenia: case report
Reactions Weekly, 2019, 1777 (1) : 132 - 132
[3] NivolumabExacerbation of immune thrombocytopenia: case report
Reactions Weekly, 2016, 1593 (1) : 141 - 141
[4] NatalizumabAcute immune thrombocytopenia: case report
Reactions Weekly, 2020, 1785 (1) : 385 - 385
[5] PeramivirSevere immune thrombocytopenia: case report
Reactions Weekly, 2014, 1526 (1) : 108 - 108
[6] VancomycinSevere immune thrombocytopenia: case report
Reactions Weekly, 2023, 1969 (1) : 368 - 368
[7] DexamethasoneParadoxical immune thrombocytopenia: case report
Reactions Weekly, 2021, 1853 (1) : 167 - 167
[8] TozinameranExacerbation of immune thrombocytopenia : case report
Reactions Weekly, 2021, 1880 (1) : 363 - 363
[9] AbciximabAcute immune thrombocytopenia: case report
Reactions Weekly, 2020, 1787 (1) : 15 - 15
[10] TozinameranSecondary immune thrombocytopenia: case report
Reactions Weekly, 2022, 1904 (1) : 438 - 438

← 1 2 3 4 5 →